S. H. Lei

Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System

Elena Ramı́rez, Olga Laosa, Pedro Ignacio Cardona Guerra et al. · British Journal of Clinical Pharmacology · 2010 · 82 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

A Pharmacovigilance Program From Laboratory Signals for the Detection and Reporting of Serious Adverse Drug Reactions in Hospitalized Patients

Antonio J. Carcas, Alberto M. Borobia, S. H. Lei et al. · Clinical Pharmacology & Therapeutics · 2009 · 80 citations

Pharmacy, Clinical Pharmacy, Pharmacology +17

DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old caucasian boy

Enrique Piñana, S. H. Lei, Marta Melgosa et al. · Journal of Clinical Pharmacy and Therapeutics · 2010 · 31 citations

Medicine, Dermatology, Pediatrics +14

Use of antifungal agents in pediatric and adult high-risk areas

Julio García‐Rodríguez, Alberto M. Borobia, JUAN MARTINEZ ORTEGA et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2011 · 11 citations

Pharmacy, Infectious Diseases, Pediatrics +14

The importance of sample size, log-mean ratios, and intrasubject variability in the acceptance criteria of 108 bioequivalence studies

P. Guerra, Olga Laosa, B. Duque et al. · European Journal of Clinical Pharmacology · 2008 · 10 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17